ACVA (ACVA) Stock Price & Analysis
ACVA (ACVA) rose 4.18% to USD 6.98 as of September 8, 2026 at 08:18 UTC, according to Nexqual real-time market data.
ACVA last closed at USD 6.98; the session ranged USD 6.6–7.17 on volume of 2,629,805 shares. Market capitalization is —, with a 52-week range of USD 4.07–11.21 (NYQ). Source: Nexqual, September 8, 2026 at 08:18 UTC.
Key Statistics (as of September 8, 2026 at 08:18 UTC)
| Price | USD 6.98 |
|---|---|
| Change | ▲ 4.18% (up) |
| Previous Close | USD 6.98 |
| Open | USD 6.98 |
| Day Range | USD 6.6 – 7.17 |
| 52-Week Range | USD 4.07 – 11.21 |
| Volume | 2,629,805 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ACVA)
Nexqual's technical model rates ACVA "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 08:18 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.18 (neutral) |
| vs SMA50 | Below (USD 7.43) |
| MACD | -0.17 (negative) |
From ACVA's Latest SEC 10-K Filing (filed 2026-02-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ALKT | Alkami Technology, Inc. | USD 19.69 | ▼ 0.96% |
| FLYW | Flywire Corporation - Voting | USD 18.55 | ▼ 1.49% |
| EVCM | EverCommerce Inc. | USD 7.92 | ▼ 0.13% |
| LFST | LifeStance Health Group, Inc. | USD 12.73 | ▼ 1.24% |
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:18 UTC. This page is informational and not investment advice.